Oral News and Research

RSS

Research sheds light on why cervical precancers disappear in some women and not in others

New research sheds light on why cervical precancers disappear in some women and not in others. Scientists say the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman’s individual immune system.

4 Jul 2005

Bone Medical completes first trial of oral parathyroid hormone product for treatment of osteoporosis

Bone Medical Ltd announced today the completion of a Phase I trial of its oral parathyroid hormone (PTH) product Perthoxal™ under development for the treatment of osteoporosis.

3 Jul 2005

Preclinical data suggest CuraGen's Velafermin may protect the gastrointestinal tract and decrease associated toxicity following exposure to radiation

New preclinical data on velafermin (CG53135), CuraGen's Phase II clinical product being developed for the prevention of oral mucositis (OM), suggesting that velafermin may protect the gastrointestinal tract and decrease associated toxicity, including enteritis and diarrhea, following exposure to radiation.

1 Jul 2005

Takeda Pharmaceuticals submits NDA for a new oral diabetes medication

Takeda Pharmaceuticals North America today announced that the company has submitted a New Drug Application (NDA) for a new oral medication that combines pioglitazone HCl and glimepiride, a sulfonylurea, to the United States Food and Drug Administration (FDA) for the treatment of type 2 diabetes.

30 Jun 2005

HRT safe for women with menopause and cancer survivors

Research shows that short-term hormone replacement therapy (HRT) is appropriate for peri- and postmenopausal women.

28 Jun 2005

Simple analysis of a bone marrow transplant patient's oral rinse indicates whether infection will develop

Simple analysis of a bone marrow transplant patient's oral rinse can give medical personnel a quick indication of the transplant's effectiveness and predict whether an infection will develop, says a University of Toronto researcher.

27 Jun 2005

The CMS demonstration project in oncology

The PricewaterhouseCoopers study that the Community Oncology Alliance (COA) commissioned shows that an estimated $13 billion will be saved from Medicare spending for cancer care through 2013. This is $8.8 billion more than the original intent of Congress in passing the Medicare Modernization Act (MMA).

22 Jun 2005

Vascular disease most common cause of male erectile dysfunction

A preeminent cardiologist reports, for the first time in a large prospective study, that certain of his patients with erectile dysfunction (ED) and heart problems can now safely use erection drugs that help up to 80% of men restore function and quality of life.

21 Jun 2005

Children who are prone to frequent ear infections may have a high number of potentially infectious bacteria

...and a relatively low number of protective bacteria in their noses, according to a study in the June issue of Archives of Otolaryngology - Head & Neck Surgery, one of the JAMA/Archives journals.

20 Jun 2005

FDA approves treatment for diarrhea caused by Cryptosporidium infection

The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.

19 Jun 2005

Early exposure to inflammatory disease multiplies Alzheimer's risk

A new study of dementia in identical twins suggests that exposure to inflammation early in life quadruples one's risk of developing Alzheimer's disease.

19 Jun 2005

Dental care needs for HIV patients continue to rise

People with HIV now are living longer and the number of dental patients treated monthly at the Oregon Health & Science University School of Dentistry's Russell Street Clinic continues to grow.

16 Jun 2005

Chromium picolinate significantly reduces weight gain associated with common antidiabetic medication

...according to a study released today. Researchers at the Pennington Biomedical Research Center (PBRC), who conducted the study, also found that chromium significantly improved blood sugar control and insulin sensitivity.

16 Jun 2005

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.

16 Jun 2005

Drinking soft drinks and other beverages through a properly positioned straw can help to minimize the risk of cavities

Americans drink roughly 576 soft drinks every year - about one and a half cans a day for everyone in the United States. Drinking these beverages places the people who may not follow proper oral hygiene techniques at a higher risk for cavities and other oral health problems.

15 Jun 2005

FDA approves Xeloda (capecitabine) oral chemotherapy

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xeloda (capecitabine) -- an innovative oral chemotherapy -- for the adjuvant (post-surgery) treatment of patients with Dukes' C colon cancer.

15 Jun 2005

Oral liquid Hydroxyurea promising for long-term use in babies with sickle cell disease

15 Jun 2005

SARS vaccine produced from plants

According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.

15 Jun 2005

Study reveals benefits of using insulin earlier

Results of an all-Canadian study announced June 13 at an international diabetes congress demonstrate that patients with type 2 diabetes can safely achieve target blood sugar (glycemic) levels faster and more frequently when insulin glargine (a basal, long-acting insulin) is added to therapy, versus using oral agents alone.

14 Jun 2005

Causes, consequences and clinical implications of alcohol-related brain shrinkage

Previous studies have demonstrated that the brains of alcoholics are smaller, lighter and "shrunken" when compared to nonalcoholic brains.

14 Jun 2005

Oral News and Research

Research sheds light on why cervical precancers disappear in some women and not in others

Bone Medical completes first trial of oral parathyroid hormone product for treatment of osteoporosis

Preclinical data suggest CuraGen's Velafermin may protect the gastrointestinal tract and decrease associated toxicity following exposure to radiation

Takeda Pharmaceuticals submits NDA for a new oral diabetes medication

HRT safe for women with menopause and cancer survivors

Simple analysis of a bone marrow transplant patient's oral rinse indicates whether infection will develop

The CMS demonstration project in oncology

Vascular disease most common cause of male erectile dysfunction

Children who are prone to frequent ear infections may have a high number of potentially infectious bacteria

FDA approves treatment for diarrhea caused by Cryptosporidium infection

Early exposure to inflammatory disease multiplies Alzheimer's risk

Dental care needs for HIV patients continue to rise

Chromium picolinate significantly reduces weight gain associated with common antidiabetic medication

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Drinking soft drinks and other beverages through a properly positioned straw can help to minimize the risk of cavities

FDA approves Xeloda (capecitabine) oral chemotherapy

Oral liquid Hydroxyurea promising for long-term use in babies with sickle cell disease

SARS vaccine produced from plants

Study reveals benefits of using insulin earlier

Causes, consequences and clinical implications of alcohol-related brain shrinkage

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News